Blindness – Talk Bio

Cirrus Therapeutics Raises $11M to Advance Gene Therapy Targeting Dry Age-Related Macular Degeneration

3 weeks ago talkbio0Tagged AAVS1 gene, Blindness, Cirrus, Dry AMD, gene therapy, IRAK3 gene, ocular immunology

Cirrus Therapeutics; gene therapy; dry AMD; IRAK-M; AAV; seed funding; ocular immunology; vision loss

EMA Identifies Very Rare Eye Condition as Side Effect of Semaglutide

5 months ago talkbio0Tagged Adverse effects, Blindness, Infrequent, Multiple Acyl Coenzyme A Dehydrogenase Deficiency, NAION, Ozempic, Rybelsus, semaglutide, Wegovy

EMA; semaglutide; rare side effect; NAION; vision loss; Ozempic; Wegovy; Rybelsus

Atsena reels in $150M to advance work on ocular gene therapies

7 months ago talkbio0Tagged Atsena, ATSN-101, ATSN-201, Blindness, Cloning Vectors, Dependovirus, Hereditary, Retinal Diseases, Retinoschisis, Juvenile, X-Linked, United States Food and Drug Administration

Atsena, Retinoschisis, Juvenile, X-Linked, United States Food and Drug Administration, Dependovirus, Cloning Vectors, Hereditary, Retinal Diseases, Blindness, ATSN-201, ATSN-101

AOA’s ‘Eye Deserve More’ Campaign Highlights the Unmatched Capabilities of the Human Eye

1 year ago talkbio0Tagged Americas Ethnicity, Blindness, Comprehensive Eye Care, Digital Eye Strain, Eye, Eye Deserve, Homo sapiens, Optometric Association, Optometry, The Eye

American Optometric Association, Eye Deserve More, The Eye, Human Eye, Eye Health, Comprehensive Eye Care, Digital Eye Strain, Vision Loss, Optometry